NASDAQ:CBIO

Catalyst Biosciences Stock News

etoro logo Buy CBIO
*Your capital is at risk
$17.98
+0.98 (+5.73%)
At Close: Jun 03, 2026
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Vericel ( VCEL – Research Report ) and Immunomedics ( IMMU – Research Report ) with bullish sentime

Invitae (NVTA) Gets a Buy Rating from Oppenheimer

01:17am, Thursday, 02'nd Apr 2020
Oppenheimer analyst Kevin DeGeeter maintained a Buy rating on Invitae (NVTA) yesterday and set a price target of $25.00. The company's shares closed last

Invitae (NVTA) Gets a Buy Rating from Oppenheimer

01:17am, Thursday, 02'nd Apr 2020
Oppenheimer analyst Kevin DeGeeter maintained a Buy rating on Invitae (NVTA – Research Report) yesterday and set a price target

FDA OKs new hemophilia treatment

05:51pm, Wednesday, 01'st Apr 2020
The FDA approves LFB Biotechnologies' Sevenfact [coagulation factor VIIa (recombinant)-jncw] for the treatment and control of bleeding episodes in adults and adolescents at least 12 years old with he
Nassim Usman became the CEO of Catalyst Biosciences, Inc. (NASDAQ:CBIO) in 2015. This analysis aims first to contrast...
Lawrence Livermore National Laboratory (LLNL) scientists are contributing to the global fight against COVID-19 by combining artificial intelligence/machine learning, bioinformatics, and supercomputing
Lawrence Livermore National Laboratory (LLNL) scientists are contributing to the global fight against COVID-19 by combining artificial intelligence/machine learning, bioinformatics and supercomputing
Radiation damage spreads among close neighbors: A single soft x-ray can destroy a protein-sized molecule. A single x-ray can unravel an enormous molecule, physicists report in the March 17 issue of Ph
There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Xeris Pharmaceuticals (XERS) and Verastem (VSTM) with
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Xeris Pharmaceuticals
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit 52-week highs March 19.) * Biomerica, Inc. (NASDAQ: BMRA) * Centogene NV (
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs March 19.) Biomerica, Inc. (NASDAQ...
There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Vascular Biogenics (VBLT) and Marinus (MRNS) with bullish
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Vascular Biogenics
Oppenheimer analyst Kevin DeGeeter maintained a Buy rating on Exact Sciences (EXAS) today. The company's shares closed last Monday at $37.90, close to its
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE